Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Michael Ruhl
Biopharma and medtech companies are using patient information across the product lifecycle to make evidence generation agile and virtual, and to move beyond single products toward end-to-end patient management.
A once-in-a-generation opportunity has opened to digitally redesign a core part of the biopharma business. Capturing the opportunity requires vision and leadership; it’s not about the technology.